Pioneers Properties For Urban Development - PRE Group (EGX:PRDC)
Egypt · Delayed Price · Currency is EGP 3.500
+0.060 (1.74%)
At close: Aug 5, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 107.21 | 1,101 | 414.02 | -153.11 | 1,077 |
Depreciation & Amortization | 56.91 | 55.35 | 56.9 | 52.09 | 31.58 |
Loss (Gain) From Sale of Assets | -4.42 | -3.59 | -294.05 | -3.11 | -699.23 |
Asset Writedown & Restructuring Costs | -261.92 | -1,654 | - | - | - |
Loss (Gain) From Sale of Investments | -294.87 | -602.39 | -122.66 | 222.67 | -34.65 |
Loss (Gain) on Equity Investments | -2.4 | -0.49 | -135.67 | -43.73 | 16.02 |
Provision & Write-off of Bad Debts | 99.77 | 101.28 | 6 | 6.25 | 36.03 |
Other Operating Activities | 1,252 | 1,748 | 1,169 | 679.32 | 123.59 |
Change in Accounts Receivable | -233.5 | -254.19 | -500.45 | -824.09 | -376.83 |
Change in Inventory | -588.39 | -537.72 | -17.57 | -51.34 | 12.47 |
Change in Accounts Payable | 1,674 | 1,387 | 167.3 | 317.18 | -281.45 |
Change in Income Taxes | -32.57 | -18.81 | 5.8 | -38.96 | - |
Change in Other Net Operating Assets | -395.46 | 1,246 | -364.7 | -1,019 | 22.2 |
Operating Cash Flow | 1,705 | 2,585 | 399.3 | -829.19 | -29.19 |
Operating Cash Flow Growth | 3.06% | 547.33% | - | - | - |
Capital Expenditures | -69.98 | -61.61 | -71.12 | -43.74 | -33.21 |
Sale of Property, Plant & Equipment | 4.25 | 4.25 | 2.16 | 3.55 | 1.58 |
Cash Acquisitions | -3.61 | -16.48 | -135.11 | -52.16 | -354.52 |
Divestitures | - | - | - | 359.36 | - |
Sale (Purchase) of Intangibles | - | - | - | -0.57 | - |
Sale (Purchase) of Real Estate | -8.28 | -9.39 | - | - | - |
Investment in Securities | 519.72 | -140.61 | -472.21 | -218.72 | -179.32 |
Other Investing Activities | 293.35 | 254.54 | 229.09 | 42.33 | 13.16 |
Investing Cash Flow | 735.46 | 30.71 | -447.2 | 90.05 | -552.3 |
Short-Term Debt Issued | - | - | 612.63 | 1,242 | - |
Long-Term Debt Issued | - | 431.83 | 944.42 | 610.98 | - |
Total Debt Issued | 386.6 | 431.83 | 1,557 | 1,853 | 967.24 |
Short-Term Debt Repaid | - | -107.21 | - | - | - |
Long-Term Debt Repaid | - | -146.87 | -234.14 | -64.12 | - |
Total Debt Repaid | -1,193 | -254.08 | -234.14 | -64.12 | -475.04 |
Net Debt Issued (Repaid) | -806.18 | 177.75 | 1,323 | 1,789 | 492.2 |
Common Dividends Paid | -47.15 | -53.36 | -50.02 | -39.46 | -0.35 |
Other Financing Activities | -1,466 | -1,967 | -1,270 | -406.95 | -66.17 |
Financing Cash Flow | -2,320 | -1,843 | 2.93 | 1,343 | 425.68 |
Foreign Exchange Rate Adjustments | -1.85 | -4.36 | -80.87 | -57.41 | 4.31 |
Miscellaneous Cash Flow Adjustments | - | 328.52 | 20.7 | - | 1,014 |
Net Cash Flow | 118.86 | 1,097 | -105.13 | 546.38 | 862.1 |
Free Cash Flow | 1,635 | 2,523 | 328.18 | -872.93 | -62.4 |
Free Cash Flow Growth | 3.02% | 668.84% | - | - | - |
Free Cash Flow Margin | 33.68% | 50.50% | 5.67% | -12.47% | -1.30% |
Free Cash Flow Per Share | 1.59 | 2.43 | 0.31 | -0.83 | -0.06 |
Cash Interest Paid | 1,359 | 1,812 | 1,163 | 582.52 | - |
Levered Free Cash Flow | -3,164 | -4,294 | -6,109 | -5,882 | - |
Unlevered Free Cash Flow | -2,280 | -3,135 | -5,367 | -5,518 | - |
Change in Net Working Capital | 2,738 | 3,424 | 5,985 | 5,963 | - |
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.